Advanced Cell Technology, Inc.
Functional Vasculature Generated From Advanced Cell Technology’s Human Embryonic Stem Cells
Published in Hematology Week, January 19th, 2009
Advanced Cell Technology, Inc. (“ACT”) (OTC: ACTC.PK) reported that it is feasible to differentiate human embryonic stem cells (hESCs) into functional human vasculature. The research, which appears in the January issue of the journal Regenerative Medicine, shows for the first time that human progenitor cells –known as hemangioblasts– have the potential for both endothelial cell (EC) and vascular smooth muscle cell (SMC) lineage differentiation. This dual potentiality is critical for the effective treatment of human vascular disease, especially the repair and formation of mature and larger-size (non-capillary) vessels.
“The cells participated in the formation of new...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week
Source: Hematology Week (2009-01-19)
More Articles from Hematology Week
- BioMed Central
Metabolic syndrome risk for veterans with PTSD - Johns Hopkins Medical Institutions
Viagra's other talents: Help a 'signaling' protein shield the heart from high blood pressure damage - New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
Simple model predicts those at risk for chronic kidney disease - World Journal of Gastroenterology
The prevalence of gluten-sensitive enteropathy in iron-deficient anemia patients - Apoptosis
Reports summarize apoptosis research from University of Quebec - Blood Substitutes
Research on blood substitutes described by scientists at Ohio State University - More from this issue of Hematology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
